av/g1-therapeutics--big.svg

COM:G1THERAPEUTICS

G1 Therapeutics, Inc.

  • Stock

Last Close

3.95

26/07 20:00

Market Cap

145.87M

Beta: -

Volume Today

492.24K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.74M
-
9.82M
466.12%
14.31M
45.65%
average payables
1.87M
-
3.39M
81.84%
3.78M
11.37%
3.53M
6.61%
3.63M
2.76%
3.23M
10.85%
5.16M
59.65%
5.71M
10.60%
average receivables
118.50K
-
2.96M
2,400%
8.39M
183.24%
11.89M
41.71%
book value per share
2.83
-
1.06
62.43%
2.08
95.99%
5.13
146.18%
-6.44
225.40%
-8.98
39.59%
-11.51
28.17%
-13.93
21.03%
1.58
111.31%
0.00
99.96%
capex per share
-0.08
-
-0.00
94.93%
-0.01
187.06%
-0.02
32.16%
-0.02
31.72%
-0.07
240.35%
-0.01
-
capex to depreciation
-5.95
-
-2.07
65.21%
-3.71
79.34%
-3.30
11.08%
-4.05
22.65%
-7.63
88.31%
-0.95
-
capex to operating cash flow
0.02
-
0.01
60.39%
0.01
58.08%
0.01
41.42%
0.01
63.95%
0.03
185.88%
0.00
-
capex to revenue
-0.10
-
-0.17
68.58%
-0.01
-
cash per share
3.01
-
1.12
62.70%
2.32
106.23%
5.70
146.36%
11.08
94.30%
7.18
35.23%
5.47
23.76%
5.27
3.65%
3.33
36.94%
0.00
99.95%
days of inventory on hand
628.43
-
1.58K
150.72%
days payables outstanding
21.48
-
524.51
-
723.67
37.97%
days sales outstanding
1.91
-
65.96
3,352.92%
78.93
19.67%
56.12
28.90%
debt to assets
0.04
-
0.19
439.68%
0.33
68.85%
0.45
36.34%
0.04
91.99%
debt to equity
-0.03
-
-0.10
234.49%
-0.14
40.07%
1.22
957.43%
0.12
89.93%
dividend yield
earnings yield
-0.39
-
-0.07
83.05%
-0.10
49.49%
-0.17
68.46%
-0.13
19.72%
-0.12
7.85%
-0.15
18.24%
-0.35
137.83%
-0.62
79.81%
-0.00
99.95%
enterprise value
14.71M
-
283.50M
1,826.65%
259.14M
8.60%
257.24M
0.73%
268.73M
4.47%
732.11M
172.44%
501.88M
31.45%
290.11M
42.19%
226.06M
22.08%
157.76B
69,686.21%
enterprise value over ebitda
-2.21
-
-26.94
1,119.29%
-8.57
68.19%
-4.23
50.66%
-3.01
28.82%
-5.67
88.51%
-5.22
7.92%
-2.03
61.10%
-1.68
17.54%
-3.99K
238,065.06%
ev to operating cash flow
-2.26
-
-20.48
804.23%
-10.31
49.66%
-5.09
50.60%
-3.62
28.98%
-7.35
103.31%
-5.99
18.49%
-2.20
63.36%
-1.76
19.96%
-4.12K
234,031.57%
ev to sales
14.11
-
543.11
3,748.52%
11.08
-
9.22
16.83%
4.41
52.19%
1.91K
43,289.39%
free cash flow per share
-5.38
-
-0.68
87.32%
-1.24
82.25%
-2.79
124.67%
-2.25
19.36%
-2.73
21.15%
-2.21
18.95%
-3.15
42.47%
-2.96
6.03%
-0.00
99.97%
free cash flow yield
-0.36
-
-0.05
87.32%
-0.08
82.25%
-0.14
69.86%
-0.12
16.46%
-0.10
12.22%
-0.12
19.08%
-0.31
151.02%
-0.55
76.70%
-0.00
99.96%
graham net net
2.73
-
1.02
62.71%
2.04
100.67%
5.06
147.88%
10.71
111.79%
6.40
40.27%
4.13
35.51%
2.78
32.60%
0.97
65.16%
0.00
99.98%
graham number
19.31
-
4.87
74.76%
8.34
71.17%
19.53
134.21%
19.25
1.43%
25.65
33.24%
26.05
1.56%
33.30
27.81%
10.95
67.11%
0.00
99.97%
income quality
0.97
-
0.68
29.78%
0.83
21.47%
0.84
1.24%
0.87
3.68%
0.81
6.67%
0.84
3.76%
0.89
5.55%
0.87
2.12%
0.80
8.31%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-54.26
-
-30.52
43.75%
-13.05
57.23%
3.94
130.17%
interest debt per share
0.27
-
1.22
345.94%
2.09
72.13%
2.16
3.24%
-0.00
100.01%
inventory turnover
0.58
-
0.23
60.11%
invested capital
-0.03
-
-0.10
234.49%
-0.14
40.07%
1.22
957.43%
0.12
89.93%
market cap
18.41M
-
306.44M
1,564.64%
306.44M
0%
361.05M
17.82%
638.02M
76.71%
991.11M
55.34%
681.43M
31.25%
428.24M
37.15%
236.89M
44.68%
157.79B
66,507.82%
net current asset value
3.37M
-
21.58M
540.26%
42.28M
95.88%
92.88M
119.70%
357.68M
285.11%
241.70M
32.43%
165.19M
31.65%
133.01M
19.48%
60.28M
54.68%
28.79M
52.23%
net debt to ebitda
0.55
-
2.18
292.96%
1.56
28.22%
1.71
9.09%
4.14
142.39%
2.01
51.47%
1.87
6.88%
0.97
48.23%
0.08
91.70%
0.71
778.58%
net income per share
-5.85
-
-0.99
83.05%
-1.48
49.49%
-3.30
122.82%
-2.56
22.51%
-3.26
27.18%
-2.62
19.52%
-3.54
34.98%
-3.38
4.37%
-0.00
99.97%
operating cash flow per share
-5.29
-
-0.68
87.20%
-1.23
81.59%
-2.78
125.58%
-2.23
19.66%
-2.66
19.05%
-2.21
16.74%
-3.15
42.47%
-2.95
6.40%
-0.00
99.97%
payables turnover
17.00
-
0.70
-
0.50
27.52%
receivables turnover
191.08
-
5.53
97.10%
4.62
16.44%
6.50
40.64%
research and ddevelopement to revenue
4.81
-
24.39
406.63%
1.62
-
2.42
49.67%
1.62
32.94%
0.53
67.38%
return on tangible assets
-1.88
-
-0.85
54.87%
-0.63
25.90%
-0.57
9.01%
-0.23
59.81%
-0.43
86.59%
-0.43
1.31%
-0.58
34.44%
-0.79
34.46%
-0.39
49.73%
revenue per share
0.85
-
0.03
96.99%
1.20
-
0.75
37.23%
1.18
56.70%
0.00
99.86%
roe
-2.07
-
-0.93
54.88%
-0.71
23.73%
-0.64
9.49%
0.40
161.79%
0.36
8.88%
0.23
37.21%
0.25
11.53%
-2.15
945.61%
-1.36
36.85%
roic
-2.07
-
-0.88
57.42%
-0.72
18.68%
-0.65
8.70%
0.44
166.73%
0.41
6.73%
0.25
37.32%
0.29
13.97%
-0.87
397.82%
-0.96
10.90%
sales general and administrative to revenue
2.59
-
6.16
137.78%
1.51
-
shareholders equity per share
2.83
-
1.06
62.43%
2.08
95.99%
5.13
146.18%
-6.44
225.40%
-8.98
39.59%
-11.51
28.17%
-13.93
21.03%
1.58
111.31%
0.00
99.96%
stock based compensation to revenue
0.07
-
0.75
955.98%
0.41
-
0.71
71.07%
0.40
43.40%
0.18
56.18%
tangible asset value
3.47M
-
21.73M
525.42%
42.59M
95.99%
93.39M
119.29%
358.82M
284.22%
255.53M
28.79%
177.35M
30.59%
143.54M
19.06%
68.75M
52.11%
35.39M
48.53%
tangible book value per share
2.83
-
1.06
62.43%
2.08
95.99%
5.13
146.18%
10.77
109.87%
6.81
36.73%
4.68
31.29%
3.42
26.91%
1.58
53.95%
0.00
99.96%
working capital
3.37M
-
21.58M
540.26%
42.28M
95.88%
92.96M
119.88%
357.77M
284.88%
251.23M
29.78%
192.95M
23.20%
215.95M
11.92%
143.91M
33.36%
85.23M
40.77%

All numbers in (except ratios and percentages)